Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metal ions involved in radical formation refer primarily to transition metals such as iron and copper that catalyze the production of highly reactive free radicals through redox cycling reactions. The most notable example is the Fenton reaction, where ferrous iron (Fe²⁺) reacts with hydrogen peroxide (H₂O₂) to generate hydroxyl radicals (·OH), which are extremely reactive and can cause significant damage to DNA, proteins, lipids, and other cellular components. Disruption of metal homeostasis leads to excessive production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), resulting in oxidative stress implicated in various diseases including cancer, cardiovascular disorders, neurodegeneration (such as Alzheimer's and Parkinson's diseases), metabolic syndromes, renal pathologies, blood disorders, among others. While some metals like zinc are essential for antioxidant defense mechanisms without participating directly in redox cycling ("redox-inert"), others like arsenic or cadmium exert toxicity by depleting glutathione or binding critical thiol groups on proteins rather than direct ROS generation. The biological impact depends on both the type/location of the metal ion complex within cells and its ability to promote local free-radical chemistry—such as DNA fragmentation if bound near nucleic acids or lipid peroxidation if associated with membranes. Note: This entry does not correspond to a single canonical therapeutic target such as an enzyme or receptor but instead describes a class of chemical mediators central to many pathological processes via their role in catalyzing free-radical reactions. Therefore it should be considered non-specific for structured drug-target databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metal ion involved in radical formation.